nodes	percent_of_prediction	percent_of_DWPC	metapath
Esmolol—ADRB1—dilated cardiomyopathy	0.502	0.543	CbGaD
Esmolol—ADRB2—dilated cardiomyopathy	0.422	0.457	CbGaD
Esmolol—Common cold—Lisinopril—dilated cardiomyopathy	0.00364	0.0562	CcSEcCtD
Esmolol—Blister—Furosemide—dilated cardiomyopathy	0.00176	0.0271	CcSEcCtD
Esmolol—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00151	0.0233	CcSEcCtD
Esmolol—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0013	0.0201	CcSEcCtD
Esmolol—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00124	0.0192	CcSEcCtD
Esmolol—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00124	0.0192	CcSEcCtD
Esmolol—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00113	0.0175	CcSEcCtD
Esmolol—Mental disability—Furosemide—dilated cardiomyopathy	0.0011	0.017	CcSEcCtD
Esmolol—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00106	0.0164	CcSEcCtD
Esmolol—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00105	0.0162	CcSEcCtD
Esmolol—Oliguria—Lisinopril—dilated cardiomyopathy	0.00103	0.0159	CcSEcCtD
Esmolol—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.000962	0.0148	CcSEcCtD
Esmolol—Wheezing—Lisinopril—dilated cardiomyopathy	0.000923	0.0142	CcSEcCtD
Esmolol—Neuropathy—Lisinopril—dilated cardiomyopathy	0.000892	0.0138	CcSEcCtD
Esmolol—Irritability—Furosemide—dilated cardiomyopathy	0.000878	0.0135	CcSEcCtD
Esmolol—Urinary retention—Furosemide—dilated cardiomyopathy	0.000874	0.0135	CcSEcCtD
Esmolol—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00085	0.0131	CcSEcCtD
Esmolol—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.000846	0.0131	CcSEcCtD
Esmolol—Confusional state—Spironolactone—dilated cardiomyopathy	0.000838	0.0129	CcSEcCtD
Esmolol—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.000757	0.0117	CcSEcCtD
Esmolol—Somnolence—Spironolactone—dilated cardiomyopathy	0.000739	0.0114	CcSEcCtD
Esmolol—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000717	0.0111	CcSEcCtD
Esmolol—Drowsiness—Furosemide—dilated cardiomyopathy	0.000709	0.0109	CcSEcCtD
Esmolol—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000685	0.0106	CcSEcCtD
Esmolol—Urticaria—Spironolactone—dilated cardiomyopathy	0.00066	0.0102	CcSEcCtD
Esmolol—Irritability—Lisinopril—dilated cardiomyopathy	0.000659	0.0102	CcSEcCtD
Esmolol—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000657	0.0101	CcSEcCtD
Esmolol—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000656	0.0101	CcSEcCtD
Esmolol—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.000628	0.0097	CcSEcCtD
Esmolol—Urethral disorder—Furosemide—dilated cardiomyopathy	0.000624	0.00962	CcSEcCtD
Esmolol—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.000617	0.00952	CcSEcCtD
Esmolol—Visual impairment—Furosemide—dilated cardiomyopathy	0.000613	0.00946	CcSEcCtD
Esmolol—Practolol—ADRB1—dilated cardiomyopathy	0.000601	0.0648	CrCbGaD
Esmolol—Pruritus—Spironolactone—dilated cardiomyopathy	0.000588	0.00907	CcSEcCtD
Esmolol—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.000587	0.00905	CcSEcCtD
Esmolol—Sweating increased—Lisinopril—dilated cardiomyopathy	0.000581	0.00897	CcSEcCtD
Esmolol—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.000581	0.00897	CcSEcCtD
Esmolol—Angiopathy—Furosemide—dilated cardiomyopathy	0.000577	0.00891	CcSEcCtD
Esmolol—Dysuria—Lisinopril—dilated cardiomyopathy	0.000558	0.00861	CcSEcCtD
Esmolol—Erythema—Furosemide—dilated cardiomyopathy	0.000554	0.00855	CcSEcCtD
Esmolol—Dizziness—Spironolactone—dilated cardiomyopathy	0.000549	0.00848	CcSEcCtD
Esmolol—Propafenone—SCN5A—dilated cardiomyopathy	0.000544	0.0586	CrCbGaD
Esmolol—Metipranolol—ADRB1—dilated cardiomyopathy	0.000543	0.0586	CrCbGaD
Esmolol—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000542	0.00837	CcSEcCtD
Esmolol—Vomiting—Spironolactone—dilated cardiomyopathy	0.000528	0.00815	CcSEcCtD
Esmolol—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.000524	0.00809	CcSEcCtD
Esmolol—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.000521	0.00804	CcSEcCtD
Esmolol—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.000521	0.00804	CcSEcCtD
Esmolol—Headache—Spironolactone—dilated cardiomyopathy	0.00052	0.00803	CcSEcCtD
Esmolol—Agitation—Furosemide—dilated cardiomyopathy	0.000509	0.00785	CcSEcCtD
Esmolol—Nausea—Spironolactone—dilated cardiomyopathy	0.000493	0.00762	CcSEcCtD
Esmolol—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000486	0.0075	CcSEcCtD
Esmolol—Sotalol—ADRB1—dilated cardiomyopathy	0.000484	0.0522	CrCbGaD
Esmolol—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000479	0.00739	CcSEcCtD
Esmolol—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000474	0.00731	CcSEcCtD
Esmolol—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.000471	0.00728	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.000468	0.00723	CcSEcCtD
Esmolol—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.000468	0.00722	CcSEcCtD
Esmolol—Dry mouth—Furosemide—dilated cardiomyopathy	0.000461	0.00712	CcSEcCtD
Esmolol—Metipranolol—ADRB2—dilated cardiomyopathy	0.000457	0.0493	CrCbGaD
Esmolol—Confusional state—Furosemide—dilated cardiomyopathy	0.000456	0.00703	CcSEcCtD
Esmolol—Shock—Furosemide—dilated cardiomyopathy	0.000445	0.00686	CcSEcCtD
Esmolol—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.000443	0.00684	CcSEcCtD
Esmolol—Flushing—Lisinopril—dilated cardiomyopathy	0.000443	0.00684	CcSEcCtD
Esmolol—Skin disorder—Furosemide—dilated cardiomyopathy	0.000439	0.00678	CcSEcCtD
Esmolol—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000437	0.00674	CcSEcCtD
Esmolol—Angiopathy—Lisinopril—dilated cardiomyopathy	0.000433	0.00668	CcSEcCtD
Esmolol—Anorexia—Furosemide—dilated cardiomyopathy	0.000431	0.00665	CcSEcCtD
Esmolol—Chills—Lisinopril—dilated cardiomyopathy	0.000428	0.00661	CcSEcCtD
Esmolol—Bevantolol—ADRB1—dilated cardiomyopathy	0.000426	0.046	CrCbGaD
Esmolol—Hypotension—Furosemide—dilated cardiomyopathy	0.000422	0.00652	CcSEcCtD
Esmolol—Mental disorder—Lisinopril—dilated cardiomyopathy	0.000418	0.00645	CcSEcCtD
Esmolol—Erythema—Lisinopril—dilated cardiomyopathy	0.000416	0.00641	CcSEcCtD
Esmolol—Sotalol—ADRB2—dilated cardiomyopathy	0.000407	0.0439	CrCbGaD
Esmolol—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000407	0.00628	CcSEcCtD
Esmolol—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000406	0.00626	CcSEcCtD
Esmolol—Somnolence—Furosemide—dilated cardiomyopathy	0.000402	0.0062	CcSEcCtD
Esmolol—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000393	0.00606	CcSEcCtD
Esmolol—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00039	0.00602	CcSEcCtD
Esmolol—Fatigue—Furosemide—dilated cardiomyopathy	0.00039	0.00601	CcSEcCtD
Esmolol—Pain—Furosemide—dilated cardiomyopathy	0.000387	0.00597	CcSEcCtD
Esmolol—Constipation—Furosemide—dilated cardiomyopathy	0.000387	0.00597	CcSEcCtD
Esmolol—Betaxolol—ADRB1—dilated cardiomyopathy	0.00038	0.041	CrCbGaD
Esmolol—Angioedema—Lisinopril—dilated cardiomyopathy	0.00038	0.00586	CcSEcCtD
Esmolol—Atenolol—ADRB1—dilated cardiomyopathy	0.000377	0.0406	CrCbGaD
Esmolol—Syncope—Lisinopril—dilated cardiomyopathy	0.000373	0.00575	CcSEcCtD
Esmolol—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000372	0.00575	CcSEcCtD
Esmolol—Bisoprolol—ADRB1—dilated cardiomyopathy	0.000367	0.0396	CrCbGaD
Esmolol—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000365	0.00564	CcSEcCtD
Esmolol—Urticaria—Furosemide—dilated cardiomyopathy	0.000359	0.00554	CcSEcCtD
Esmolol—Bevantolol—ADRB2—dilated cardiomyopathy	0.000359	0.0387	CrCbGaD
Esmolol—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000357	0.00551	CcSEcCtD
Esmolol—Chest pain—Lisinopril—dilated cardiomyopathy	0.000354	0.00546	CcSEcCtD
Esmolol—Anxiety—Lisinopril—dilated cardiomyopathy	0.000353	0.00544	CcSEcCtD
Esmolol—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.000351	0.00542	CcSEcCtD
Esmolol—Acebutolol—ADRB1—dilated cardiomyopathy	0.000348	0.0375	CrCbGaD
Esmolol—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000346	0.00534	CcSEcCtD
Esmolol—Oxprenolol—ADRB1—dilated cardiomyopathy	0.000345	0.0372	CrCbGaD
Esmolol—Confusional state—Lisinopril—dilated cardiomyopathy	0.000342	0.00528	CcSEcCtD
Esmolol—Oedema—Lisinopril—dilated cardiomyopathy	0.000339	0.00523	CcSEcCtD
Esmolol—Shock—Lisinopril—dilated cardiomyopathy	0.000334	0.00515	CcSEcCtD
Esmolol—Skin disorder—Lisinopril—dilated cardiomyopathy	0.000329	0.00508	CcSEcCtD
Esmolol—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000328	0.00506	CcSEcCtD
Esmolol—Asthenia—Furosemide—dilated cardiomyopathy	0.000324	0.005	CcSEcCtD
Esmolol—Anorexia—Lisinopril—dilated cardiomyopathy	0.000323	0.00499	CcSEcCtD
Esmolol—Pruritus—Furosemide—dilated cardiomyopathy	0.00032	0.00494	CcSEcCtD
Esmolol—Betaxolol—ADRB2—dilated cardiomyopathy	0.00032	0.0345	CrCbGaD
Esmolol—Hypotension—Lisinopril—dilated cardiomyopathy	0.000317	0.00489	CcSEcCtD
Esmolol—Atenolol—ADRB2—dilated cardiomyopathy	0.000317	0.0341	CrCbGaD
Esmolol—Alprenolol—ADRB1—dilated cardiomyopathy	0.000316	0.034	CrCbGaD
Esmolol—Bisoprolol—ADRB2—dilated cardiomyopathy	0.000309	0.0333	CrCbGaD
Esmolol—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000305	0.0047	CcSEcCtD
Esmolol—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000302	0.00467	CcSEcCtD
Esmolol—Somnolence—Lisinopril—dilated cardiomyopathy	0.000301	0.00465	CcSEcCtD
Esmolol—Dizziness—Furosemide—dilated cardiomyopathy	0.000299	0.00461	CcSEcCtD
Esmolol—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000299	0.00461	CcSEcCtD
Esmolol—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000295	0.00455	CcSEcCtD
Esmolol—Metoprolol—ADRB1—dilated cardiomyopathy	0.000293	0.0316	CrCbGaD
Esmolol—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000293	0.00452	CcSEcCtD
Esmolol—Fatigue—Lisinopril—dilated cardiomyopathy	0.000292	0.00451	CcSEcCtD
Esmolol—Acebutolol—ADRB2—dilated cardiomyopathy	0.000292	0.0315	CrCbGaD
Esmolol—Oxprenolol—ADRB2—dilated cardiomyopathy	0.00029	0.0313	CrCbGaD
Esmolol—Pain—Lisinopril—dilated cardiomyopathy	0.00029	0.00448	CcSEcCtD
Esmolol—Constipation—Lisinopril—dilated cardiomyopathy	0.00029	0.00448	CcSEcCtD
Esmolol—Vomiting—Furosemide—dilated cardiomyopathy	0.000287	0.00444	CcSEcCtD
Esmolol—Headache—Furosemide—dilated cardiomyopathy	0.000283	0.00437	CcSEcCtD
Esmolol—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000279	0.00431	CcSEcCtD
Esmolol—Pindolol—ADRB1—dilated cardiomyopathy	0.000272	0.0293	CrCbGaD
Esmolol—Urticaria—Lisinopril—dilated cardiomyopathy	0.000269	0.00416	CcSEcCtD
Esmolol—Nausea—Furosemide—dilated cardiomyopathy	0.000268	0.00414	CcSEcCtD
Esmolol—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000268	0.00414	CcSEcCtD
Esmolol—Alprenolol—ADRB2—dilated cardiomyopathy	0.000265	0.0286	CrCbGaD
Esmolol—ADRB2—Adrenoceptors—ADRB1—dilated cardiomyopathy	0.000252	0.116	CbGpPWpGaD
Esmolol—Metoprolol—ADRB2—dilated cardiomyopathy	0.000247	0.0266	CrCbGaD
Esmolol—Asthenia—Lisinopril—dilated cardiomyopathy	0.000243	0.00376	CcSEcCtD
Esmolol—Pruritus—Lisinopril—dilated cardiomyopathy	0.00024	0.0037	CcSEcCtD
Esmolol—Pindolol—ADRB2—dilated cardiomyopathy	0.000228	0.0246	CrCbGaD
Esmolol—Dizziness—Lisinopril—dilated cardiomyopathy	0.000224	0.00346	CcSEcCtD
Esmolol—Propafenone—ADRB1—dilated cardiomyopathy	0.000216	0.0233	CrCbGaD
Esmolol—Vomiting—Lisinopril—dilated cardiomyopathy	0.000216	0.00333	CcSEcCtD
Esmolol—Headache—Lisinopril—dilated cardiomyopathy	0.000212	0.00328	CcSEcCtD
Esmolol—ADRB1—Adrenoceptors—ADRB2—dilated cardiomyopathy	0.000209	0.0964	CbGpPWpGaD
Esmolol—Nausea—Lisinopril—dilated cardiomyopathy	0.000201	0.00311	CcSEcCtD
Esmolol—Propranolol—ADRB1—dilated cardiomyopathy	0.000148	0.016	CrCbGaD
Esmolol—Propranolol—ADRB2—dilated cardiomyopathy	0.000125	0.0134	CrCbGaD
Esmolol—ADRB2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	8.93e-05	0.0412	CbGpPWpGaD
Esmolol—ADRB2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	7.5e-05	0.0346	CbGpPWpGaD
Esmolol—ADRB1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	7.39e-05	0.0341	CbGpPWpGaD
Esmolol—ADRB2—Arf6 signaling events—AGTR1—dilated cardiomyopathy	7.27e-05	0.0335	CbGpPWpGaD
Esmolol—ADRB1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	6.22e-05	0.0287	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	5.78e-05	0.0266	CbGpPWpGaD
Esmolol—ADRB2—Arf6 trafficking events—AGTR1—dilated cardiomyopathy	5.75e-05	0.0265	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	5.65e-05	0.0261	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	5.62e-05	0.0259	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	5.5e-05	0.0253	CbGpPWpGaD
Esmolol—ADRB2—Arf6 trafficking events—ITGB1—dilated cardiomyopathy	5.26e-05	0.0243	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	4.66e-05	0.0215	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	4.56e-05	0.021	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Other—CXCR3—dilated cardiomyopathy	4.09e-05	0.0189	CbGpPWpGaD
Esmolol—ADRB1—Endothelin Pathways—RAF1—dilated cardiomyopathy	3.81e-05	0.0175	CbGpPWpGaD
Esmolol—ADRB2—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	3.1e-05	0.0143	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	2.67e-05	0.0123	CbGpPWpGaD
Esmolol—ADRB1—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	2.56e-05	0.0118	CbGpPWpGaD
Esmolol—ADRB2—Arf6 signaling events—EGFR—dilated cardiomyopathy	2.44e-05	0.0112	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	2.26e-05	0.0104	CbGpPWpGaD
Esmolol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	2.21e-05	0.0102	CbGpPWpGaD
Esmolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	2.21e-05	0.0102	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.96e-05	0.00902	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	1.91e-05	0.00882	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	1.82e-05	0.00838	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	1.78e-05	0.0082	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	1.72e-05	0.00794	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	1.68e-05	0.00773	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	1.68e-05	0.00773	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	1.64e-05	0.00756	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	1.64e-05	0.00756	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	1.56e-05	0.00718	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	1.52e-05	0.00703	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	1.5e-05	0.00693	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	1.48e-05	0.0068	CbGpPWpGaD
Esmolol—ADRB2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	1.47e-05	0.00678	CbGpPWpGaD
Esmolol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	1.43e-05	0.00658	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	1.29e-05	0.00594	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	1.28e-05	0.00588	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	1.28e-05	0.00588	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	1.26e-05	0.00581	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	1.25e-05	0.00576	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	1.25e-05	0.00576	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	1.22e-05	0.00564	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	1.19e-05	0.00547	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	1.16e-05	0.00535	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	1.12e-05	0.00518	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.81e-06	0.00452	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	9.6e-06	0.00443	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	9.31e-06	0.00429	CbGpPWpGaD
Esmolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	9.07e-06	0.00418	CbGpPWpGaD
Esmolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	8.87e-06	0.00409	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.21e-06	0.00332	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.21e-06	0.00332	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	7.05e-06	0.00325	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	7.05e-06	0.00325	CbGpPWpGaD
Esmolol—ADRB1—GPCR ligand binding—AGT—dilated cardiomyopathy	6.91e-06	0.00318	CbGpPWpGaD
Esmolol—ADRB2—GPCR ligand binding—AGT—dilated cardiomyopathy	6.75e-06	0.00311	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.7e-06	0.00309	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	6.56e-06	0.00302	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.55e-06	0.00302	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.55e-06	0.00302	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	6.41e-06	0.00295	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	6.41e-06	0.00295	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	6.35e-06	0.00293	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	6.09e-06	0.00281	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	5.96e-06	0.00275	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	5.77e-06	0.00266	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.55e-06	0.00256	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	5.42e-06	0.0025	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	5.26e-06	0.00243	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	5.04e-06	0.00232	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	4.93e-06	0.00227	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	4.78e-06	0.0022	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.36e-06	0.00201	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	4.26e-06	0.00197	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4.08e-06	0.00188	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	4e-06	0.00184	CbGpPWpGaD
Esmolol—ADRB1—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.9e-06	0.0018	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.87e-06	0.00178	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.87e-06	0.00178	CbGpPWpGaD
Esmolol—ADRB2—GPCR downstream signaling—AGT—dilated cardiomyopathy	3.82e-06	0.00176	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	3.78e-06	0.00174	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	3.78e-06	0.00174	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.71e-06	0.00171	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RAC1—dilated cardiomyopathy	3.63e-06	0.00167	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.6e-06	0.00166	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—AGT—dilated cardiomyopathy	3.54e-06	0.00163	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	3.52e-06	0.00162	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—AGT—dilated cardiomyopathy	3.47e-06	0.0016	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	3.41e-06	0.00157	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.97e-06	0.00137	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	2.91e-06	0.00134	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	2.82e-06	0.0013	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.46e-06	0.00113	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.43e-06	0.00112	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—RAF1—dilated cardiomyopathy	2.41e-06	0.00111	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	2.37e-06	0.00109	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RAC1—dilated cardiomyopathy	2.19e-06	0.00101	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RAC1—dilated cardiomyopathy	2.14e-06	0.000988	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—AGT—dilated cardiomyopathy	2.09e-06	0.000965	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—AGT—dilated cardiomyopathy	2.05e-06	0.000944	CbGpPWpGaD
Esmolol—ADRB1—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.69e-06	0.000778	CbGpPWpGaD
Esmolol—ADRB2—Signaling by GPCR—EGFR—dilated cardiomyopathy	1.65e-06	0.000761	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—RAF1—dilated cardiomyopathy	1.45e-06	0.00067	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—RAF1—dilated cardiomyopathy	1.42e-06	0.000655	CbGpPWpGaD
Esmolol—ADRB1—Signaling Pathways—EGFR—dilated cardiomyopathy	9.96e-07	0.000459	CbGpPWpGaD
Esmolol—ADRB2—Signaling Pathways—EGFR—dilated cardiomyopathy	9.75e-07	0.000449	CbGpPWpGaD
